National Health Investors (NYSE:NHI) Issues FY 2026 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 4.940-4.990 for the period, compared to the consensus estimate of 4.060. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. KeyCorp increased their price objective on National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a report on Tuesday, January 20th. National Bank Financial set a $85.00 target price on shares of National Health Investors in a report on Tuesday, January 20th. Finally, Wells Fargo & Company increased their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $85.57.

National Health Investors Price Performance

National Health Investors stock traded down $0.62 on Thursday, reaching $87.51. The company’s stock had a trading volume of 440,480 shares, compared to its average volume of 241,481. The business’s fifty day moving average price is $81.37 and its 200 day moving average price is $78.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 10.64 and a current ratio of 10.64. The company has a market cap of $4.17 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 3.04 and a beta of 0.66. National Health Investors has a twelve month low of $66.41 and a twelve month high of $91.38.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $0.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.43). The business had revenue of $105.82 million during the quarter, compared to the consensus estimate of $95.12 million. National Health Investors had a net margin of 41.38% and a return on equity of 10.17%. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Equities analysts expect that National Health Investors will post 4.41 earnings per share for the current fiscal year.

Institutional Trading of National Health Investors

A number of hedge funds and other institutional investors have recently modified their holdings of NHI. EverSource Wealth Advisors LLC raised its position in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of National Health Investors in the 4th quarter valued at $33,000. Advisory Services Network LLC bought a new stake in shares of National Health Investors during the third quarter worth $65,000. Triumph Capital Management acquired a new position in shares of National Health Investors during the third quarter valued at $66,000. Finally, NewEdge Advisors LLC lifted its stake in shares of National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.